All News

Found 1,994 articles

• OpGen, Inc. Announces $23.6 Million Series A Financing

  9/12/2007

• Tobira Therapeutics Inc. Completes $31 Million Series A Financing; Names CEO

  8/2/2007

• Incyte Corporation Cites Encouraging Clinical Data in Multiple Programs; Announces Second Quarter 2007 Financial Results

  7/26/2007

• Incyte Corporation: Phase IIa Study Results Demonstrate that Once-Daily 200 mg Dosing of INCB9471 Provided Potent and Prolonged Antiviral Activity in HIV-Infected Patients

  7/24/2007

• Incyte Corporation to Report Second Quarter 2007 Financial Results and Provide Update on Drug Discovery & Development Programs on July 26

  7/10/2007

• Piper Jaffray to Host 2nd Annual London Health Care Conference

  6/13/2007

• Incyte Corporation to Present at Upcoming Investor Conferences

  6/5/2007

• Incyte Corporation to Present at Upcoming Investment Conferences

  5/18/2007

• Incyte Corporation Reviews Progress in Multiple Drug Development Programs and Announces First Quarter 2007 Financial Results

  5/3/2007

• Incyte Corporation to Present at the Morgan Stanley Global Healthcare Unplugged Conference

  4/24/2007

• Incyte Corporation to Report First Quarter 2007 Financial Results and Provide Update on Drug Discovery & Development Programs on May 3

  4/19/2007

• Robert B. Stein, M.D., Ph.D., Joins Archemix Corporation Board of Directors

  4/3/2007

• Incyte Corporation Reviews Recent Progress In Multiple Programs; Announces 2006 Financial Results And 2007 Financial Guidance

  2/15/2007

• Incyte Corporation To Report 2006 Financial Results And 2007 Financial Guidance And Provide Update On Drug Discovery & Development Programs On February 15

  1/25/2007

• Incyte Corporation To Report Positive Preliminary Clinical Results From HIV And Diabetes Programs And Highlight Progress In Several Drug Development Programs At The 25th JPMorgan Healthcare Conference

  1/8/2007

• Incyte Corporation To Present At The 25th Annual JP Morgan Healthcare Conference

  1/4/2007

• Registration Statement Declared Effective For The Resale Of Incyte Corporation's 3½% Convertible Senior Notes Originally Issued In September 2006

  12/11/2006

• Incyte Corporation To Present At 18th Annual Piper Jaffray Health Care Conference

  11/28/2006

• Incyte Corporation Announces Filing Of Registration Statement For Resale Of 3 1/2% Convertible Senior Notes Due 2011

  11/22/2006

• Incyte Corporation To Present At JMP Securities Healthcare Conference

  11/14/2006